Top Institutions in Ophthalmology and Hematology
Institutions were ranked based on their known expertise in rare ocular diseases, hematologic disorders involving plasminogen deficiency, and leadership in translational research and clinical trials for rare systemic protein deficiencies.
-
#1
National Eye Institute (NEI), National Institutes of Health
Bethesda, MD
NEI leads in research on rare ocular diseases including ligneous conjunctivitis and has extensive programs in translational research for ocular manifestations of systemic diseases.
-
#2
Mayo Clinic
Rochester, MN
Mayo Clinic has multidisciplinary expertise in rare hematologic disorders and their ocular manifestations, with a strong clinical and research focus on plasminogen deficiency and ligneous conjunctivitis.
-
#3
Massachusetts General Hospital (MGH), Harvard Medical School
Boston, MA
MGH is a leader in both ophthalmology and hematology research, with active involvement in rare systemic diseases and novel therapeutic development including plasminogen replacement therapies.
-
#4
University of California, San Francisco (UCSF) Medical Center
San Francisco, CA
UCSF has a strong rare disease program with expertise in systemic protein deficiencies and their ocular manifestations, offering advanced diagnostic and therapeutic options.